Pharmaceutical Product Monograph: Ampicillin & Sulbactam Sodium Injection
In the pharmaceutical industry, the combination of Ampicillin and Sulbactam (often referred to as Sultamicillin in oral form or Co-Sultamicillin) is a broad-spectrum Beta-lactamase inhibitor antibiotic. As a pharmacist and manufacturer, I view this formulation as a “Potentiated Penicillin”—it is technically designed to extend the reach of Ampicillin to include bacteria that have evolved to produce destructive enzymes.
At your WHO-GMP facility in Mumbai, this injection is a high-volume SKU for Secondary and Tertiary Care settings. It is a cornerstone for treating mixed infections where both aerobic and anaerobic bacteria are suspected.
Therapeutic Profile: Primary Indications
Ampicillin/Sulbactam is indicated for the treatment of moderate-to-severe infections caused by susceptible strains of microorganisms.
| Indication | Clinical Context | Technical Rationale |
| Intra-abdominal Infections | Peritonitis / Appendicitis | Provides the necessary “double coverage” for gut-related bacteria and anaerobes. |
| Gynecological Infections | PID / Endometritis | Treats complex pelvic inflammatory diseases often involving mixed flora. |
| Skin & Soft Tissue | Diabetic Foot / Cellulitis | Effective against Staphylococcus aureus and Bacteroides species in deep tissue infections. |
| Aspiration Pneumonia | Respiratory Care | The “drug of choice” for pneumonia caused by inhaling stomach contents or mouth bacteria. |
| Pediatric Epiglotitis | Critical ENT | Rapidly reduces life-threatening airway swelling caused by H. influenzae. |
Mechanism: The “Suicide Inhibition” Strategy
This combination works through a dual-action biochemical process:
Ampicillin (The Bactericidal Agent): It binds to Penicillin-Binding Proteins (PBPs) in the bacterial cell wall. This prevents the “cross-linking” of the cell wall, causing the bacteria to burst (osmotic lysis).
Sulbactam (The Beta-Lactamase Inhibitor): Many bacteria produce enzymes called Beta-lactamases that destroy Ampicillin. Sulbactam is a “Suicide Inhibitor”—it binds irreversibly to these enzymes, “sacrificing” itself so that the Ampicillin remains active and effective.
The Pharmacist’s “Technical Warning”
The “Allergy” Screen: As a pharmacist, I must emphasize that this drug is strictly contraindicated in patients with a history of Penicillin Anaphylaxis. Cross-reactivity with Cephalosporins is technically possible.
Renal Adjustment: Because both drugs are excreted by the kidneys, the dosage interval must be adjusted in patients with Renal Impairment ($GFR < 30 \text{ mL/min}$).
The “Mono” Rash: Similar to Amoxicillin, giving this to a patient with Infectious Mononucleosis (a virus) will result in a widespread, non-allergic skin rash.
Stability: Once reconstituted, the solution is stable for only 1 hour at room temperature (or up to 8-24 hours in a refrigerator, depending on the diluent used).
The Manufacturer’s Perspective: Technical & Export
From a production and B2B standpoint at your facility in Mumbai:
The “Aseptic Filling” USP: On your digital marketplace, highlight your State-of-the-art Aseptic Powder Suite. Ampicillin/Sulbactam is highly sensitive to moisture; ensuring a 100% dry, sterile environment during filling is a technical hallmark of your WHO-GMP compliance.
Ratio Precision: The standard ratio is 2:1 (e.g., 1g Ampicillin to 0.5g Sulbactam). For B2B tenders, emphasize your precision in weight-uniformity, which ensures consistent therapeutic outcomes in critical care.
Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for 1.5g and 3g vials to support your registration in international tenders for hospital and emergency supplies.